Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

NCT02626715 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
Myelodysplastic Syndrome (MDS)
Hematopoietic Stem Cell Transplant (HSCT)

Interventions

DRUG: Reduced-Intensity Conditioning Regimen
DRUG: Myeloablative Conditioning Regimen

Sponsor

Randy Windreich